PINI, Luigi Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.051
EU - Europa 10.324
AS - Asia 8.248
SA - Sud America 1.119
AF - Africa 161
Continente sconosciuto - Info sul continente non disponibili 128
OC - Oceania 15
Totale 39.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.747
GB - Regno Unito 3.421
IT - Italia 3.282
CN - Cina 2.541
SG - Singapore 2.329
HK - Hong Kong 940
VN - Vietnam 872
BR - Brasile 845
SE - Svezia 708
DE - Germania 547
UA - Ucraina 487
FI - Finlandia 429
FR - Francia 410
BD - Bangladesh 345
RU - Federazione Russa 287
KR - Corea 279
TR - Turchia 274
NL - Olanda 224
CA - Canada 173
BG - Bulgaria 171
IN - India 151
ID - Indonesia 124
AR - Argentina 88
IE - Irlanda 75
MX - Messico 73
IQ - Iraq 50
JP - Giappone 50
EC - Ecuador 47
ES - Italia 43
CO - Colombia 42
ZA - Sudafrica 41
BE - Belgio 38
AE - Emirati Arabi Uniti 37
PK - Pakistan 36
CL - Cile 31
CH - Svizzera 30
PL - Polonia 29
AT - Austria 28
MA - Marocco 26
VE - Venezuela 25
IR - Iran 24
MY - Malesia 20
PH - Filippine 19
BY - Bielorussia 18
TN - Tunisia 18
NP - Nepal 17
UZ - Uzbekistan 16
DZ - Algeria 15
SA - Arabia Saudita 14
EU - Europa 13
PY - Paraguay 13
IL - Israele 12
LT - Lituania 12
PE - Perù 12
RO - Romania 12
SN - Senegal 12
TH - Thailandia 12
CR - Costa Rica 11
EG - Egitto 11
KE - Kenya 10
NO - Norvegia 10
UY - Uruguay 10
AU - Australia 9
ET - Etiopia 9
JO - Giordania 9
LB - Libano 9
GE - Georgia 8
JM - Giamaica 8
KZ - Kazakistan 8
PT - Portogallo 8
AL - Albania 7
TW - Taiwan 7
AO - Angola 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
GR - Grecia 6
NI - Nicaragua 6
PA - Panama 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
YE - Yemen 6
AZ - Azerbaigian 5
BH - Bahrain 5
QA - Qatar 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
PR - Porto Rico 4
SI - Slovenia 4
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
Totale 38.897
Salva come PNG Salva come JPEG
Città #
Southend 2.672
Ashburn 1.796
Santa Clara 1.761
Fairfield 1.719
Singapore 1.423
Woodbridge 1.392
Jacksonville 1.011
Houston 975
Hefei 922
Hong Kong 917
Chandler 798
Dearborn 640
Wilmington 636
Seattle 599
Cambridge 573
Ann Arbor 561
Beijing 467
London 398
San Jose 388
Nyköping 361
Los Angeles 311
Milan 305
Council Bluffs 302
Chicago 285
Helsinki 272
Ho Chi Minh City 272
Seoul 261
The Dalles 257
Hanoi 218
Modena 201
Princeton 198
New York 184
San Diego 176
Rome 171
Sofia 167
Eugene 162
Lauterbourg 148
Izmir 142
Buffalo 141
Dallas 140
Moscow 105
Salt Lake City 87
Jakarta 78
Turin 74
Naples 73
Bologna 72
Shanghai 72
Des Moines 71
Redwood City 69
Dublin 68
Orem 68
São Paulo 63
Columbus 49
Toronto 45
Genoa 44
Tokyo 44
Palermo 43
Phoenix 41
Atlanta 40
Florence 40
Haiphong 40
Tampa 38
Da Nang 37
Elk Grove Village 37
Nanjing 37
Rio de Janeiro 37
Verona 36
Brescia 35
Brooklyn 35
Brussels 35
Frankfurt am Main 35
Dong Ket 33
Boardman 32
Ottawa 32
Bianco 29
Catania 29
Chennai 29
Norwalk 29
Bremen 28
Paris 28
Falkenstein 27
Guangzhou 27
Lancaster 27
Miami 27
Falls Church 26
Mexico City 26
Montreal 26
Munich 26
San Francisco 26
Denver 25
Miano 25
Parma 23
Perugia 23
Philadelphia 23
Boston 22
Sterling 22
Tulare 22
Baghdad 20
Fremont 20
Jinan 20
Totale 26.722
Salva come PNG Salva come JPEG
Nome #
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.268
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. 801
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 424
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 419
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 398
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 380
Basal cutaneous pain threshold in headache patients 374
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 367
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 364
Endocannabinoids in chronic migraine: CSF findings suggest a system failure 361
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 360
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 354
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 342
Nimodipine in otolaryngology: from past evidence to clinical perspectives 340
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 320
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 315
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 315
A case-control study of visually evoked postural responses in childhood with primary headaches 313
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 312
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 310
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 308
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis 306
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 303
A preliminary study on the relationship between central auditory processing and childhood primary headaches in the intercritical phase 302
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 301
Effect of rofecoxib on nociception and the serotonin system in the rat brain 291
NF-kappa B activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks 290
Diamo parole al dolore. La percezione del disagio e della difficoltà nella vita quotidiana delle bambine e dei bambini 289
Italian guidelines for primary headaches: 2012 revised version. 288
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 287
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study 282
A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs 278
Anti-epileptic drugs in the preventive treatment of migraine headache : a brief review. 277
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 276
HIGH EFFICACY AND LOW-FREQUENCY OF HEADACHE RECURRENCE AFTER ORAL SUMATRIPTAN 274
Long-term follow-up of patients treated for chronic headache with analgesic overuse 274
Disposition of naproxen after oral administration during and between migraine attacks. 273
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 273
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse 271
Headaches associated with chronic use of analgesics: A therapeutic approach 268
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 267
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 259
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 257
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 256
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 255
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 254
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 253
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 253
Analgesic abuse in chronic headache sufferers 251
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 251
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 249
Phenytoin-Treatment Of Rdeb Vegetans 249
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 249
An unusual case report on the possible role of Warfarin in migraine prophylaxis 249
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders 248
INTERNATIONAL-HEADACHE-SOCIETY CLASSIFICATION - INTEROBSERVER RELIABILITY IN THE DIAGNOSIS OF PRIMARY HEADACHES 248
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 244
Lack of association between five serotonin metabolism-relatedgenes and medication overuse headache. 242
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 240
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 238
Risk-benefit and cost-benefit ratio in headache treatment 237
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium 236
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 235
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 235
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 234
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 231
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 228
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 228
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 227
An emerging problem in clinical practice: how to treat chronic headache patients. 225
Plasma glutathione level in chronic headache drug abuser patients 224
Different characteristics of triptans 224
Triptans: the experience of a clinical pharmacologist in clinical practice. 223
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 221
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 221
Analysis on the use of migraine preventative drugs in current clinical practice 220
Chronic daily headache: how to manage it? 220
Relevance of analgesic abuse in the maintenance of chronic headaches 218
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels 218
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 218
Homocysteine levels and cardiovascular disease in migraine with aura 217
High prevalence of patent foramen ovale in migraine with aura 217
DOES CHRONIC USE OF SUMATRIPTAN INDUCE DEPENDENCE 215
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 214
Pharmacokinetics of tia profenic acid in headache attacks - a preliminary report 213
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study 211
Tacrolimus pharmacokinetics in kidney transplant recipients. 210
Ambiti e limiti delle prescrizioni farmaceutiche nell'esercizio dell'odontoiatria e protesi dentaria 209
Naloxone-reverisble antinociception by paracetamol in the rat. 208
Active reporting scheme: an example to evaluate specific adverse drug reactions. 208
Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report 208
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 208
Urinary neopterin in malignant lymphoma 207
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment. 206
Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial 206
Increased levels of Neurotrophins are not specific for chronic migraine: Evidence from primary fibromyalgia syndrome 205
A CB1 agonist in the treatment of medication-overuse headache: a possible therapeutic strategy 204
Circadian variations of proopiocortin-related peptides in children with migraine. 203
PHARMACOKINETICS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS 203
Influence of chronic therapy with flunarizine on glucose, insulin and C-peptide metabolism 202
Totale 28.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.854
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.843 0 450 319 326 66 75 194 139 279 198 443 354
2022/20232.399 308 231 141 208 268 363 49 213 300 51 120 147
2023/20242.231 116 143 158 171 370 166 200 268 93 83 223 240
2024/20256.336 282 117 155 473 1.230 883 341 311 840 467 595 642
2025/202611.263 716 540 1.207 1.289 1.331 822 1.203 664 1.084 947 826 634
2026/2027821 540 281 0 0 0 0 0 0 0 0 0 0
Totale 39.046